Watch Ticker

Intra-Cellular Therapies Inc.

Go to Intra-Cellular Therapies Inc. Website

$72.30

(%)

Live

Previous Close

$72.3

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$7.6 billion USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in n...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Zacks Equity Research - Will Intra-Cellular Therapies (ITCI) Report Negative Q1 Earnings? What You Should Know

Intra-Cellular (ITCI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Related tickers: ITCI.

Read Full Article

Intra-Cellular Therapies Inc. - Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) (“Intra-Cellular Therapies”), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it has completed the sale of an additional 1,027,397 shares of its common stock at a public offering price of $73.00 per share on April 24, 2024, pursuant to the full exercise of the option granted by Intra-Cellular Therapies to the underwriters in connection with its previously announced public offering of 6,849,316 shares of common stock, which closed on April 22, 2024.

Related tickers: ITCI.

Read Full Article

Trending Tickers

DATS

XNAS

$0.00

0.00 (0.00%)

LASE

XNAS

$2.05

(%)

NYCB

XNYS

$2.79

(%)

PACW

XNAS

$7.54

(%)

MLGO

XNAS

$2.46

(%)